ArticleBMC pharmacology & toxicology2025
Exploring the mechanisms of Benzo[a]pyrene-induced lung adenocarcinoma based on network toxicology and machine learning.
Article in BMC pharmacology & toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundBenzo[a]pyrene (BaP) is a pervasive environmental carcinogen present in PM2.5, tobacco smoke, and vehicular emissions. Although its toxic potential is recognized, its molecular mechanisms in lung carcinogenesis are unclear. The purpose of this study is to find the core target of BaP-induced lung cancer and explain its pathological process by integrated calculation.
methodsThe toxicity of BaP was assessed by ProTox 3.0 and ADMET Lab 3.0. Potential targets of BaP were identified through comparative analysis of chemical toxicology databases Comparative Toxicogenomics Database (CTD) and lung adenocarcinoma genomic data from The Cancer Genome Atlas (TCGA), and Gene Expression Omnibus (GEO). Machine learning (ML) algorithms were applied to screen the signature genes, complemented by immune infiltration analysis. Molecular docking simulations were conducted to evaluate the binding capacity between BaP and identified protein targets.
resultsMachine learning and immune infiltration identified five core genes (KDR, NQO1, MMP12, MMP13, PLAU) which were related to BaP-induced oncogenesis, especially in angiogenesis and extracellular matrix remodeling. The results of molecular docking validated direct interactions between BaP and these targets, with docking scores < -5 kcal/mol confirming strong binding affinities.
conclusionsThis study revealed the multi-target mechanism of BaP in promoting lung cancer development, primarily involved in angiogenesis and extracellular matrix reorganization. These findings provided novel insights into BaP’s carcinogenic mechanisms and offered the potential targets for environmental chemical-induced lung cancer interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.